Valuing clinical strategies early in their development
- PMID: 1728210
- DOI: 10.7326/0003-4819-116-3-263
Valuing clinical strategies early in their development
Comment on
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease.Ann Intern Med. 1992 Feb 1;116(3):177-82. doi: 10.7326/0003-4819-116-3-177. Ann Intern Med. 1992. PMID: 1728202 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources